Rx Medicare

The drugmaker Sanofi-Aventis will donate millions of doses of a vaccine that offers protection against the H1N1 (swine flu) virus to the WHO once the vaccine is ready, the company’s chief executive officer announced Tuesday, Reuters reports (Elsner, Reuters, 6/17). The

Read More…

Related Posts

• Poor Evidence For Effectiveness Of Influenza Vaccines In Elderly
• A(H1N1) Influenza Pandemic: Sanofi Pasteur’s Global Response
• European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
• Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses In Animal Studies
• Inovio Biomedical, National Microbiology Laboratory, And University Of Pennsylvania To Evaluate Candidate DNA Vaccines Against “Swine” Influenza A
• Inviragen Researching Vaccines To Protect Against Pandemic And Seasonal Influenza Viruses
• AmpVacs A Broadly Protective Synthetic Influenza A Vaccine
• Dog Flu: Canine Influenza (CIV) In Dogs
• Dry Winters Linked To Seasonal Outbreaks Of Influenza
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
• WHO Will Meet To Decide If H1N1 Has Peaked
• Mandatory Policy Boosts Influenza Vaccination Rate Among Health Care Workers
• European Medicines Agency Updates On Pandemic Influenza
• Get Vaccinated For Influenza; It’s Not Too Late – Alabama Department of Public Health

Tags: aventis, donate, efficacy, glaxosmithkline, influenza, sanofi, vaccines, will

This entry was posted on Friday, June 19th, 2009 at 3:06 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.